NCT00098397View on ClinicalTrials.gov

FR901228 in Treating Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

September 30, 2005

Conditions
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
Interventions
DRUG

romidepsin

Given IV

OTHER

laboratory biomarker analysis

Optional correlative studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00098397 - FR901228 in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter